PubMed:32907635 / 201-512 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":264,"end":270},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000055"}],"text":"The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":183,"end":191},"obj":"Disease"},{"id":"T3","span":{"begin":201,"end":214},"obj":"Disease"},{"id":"T4","span":{"begin":271,"end":283},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":193,"end":194},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T6","span":{"begin":264,"end":270},"obj":"http://purl.obolibrary.org/obo/UBERON_0000055"},{"id":"T7","span":{"begin":300,"end":310},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":271,"end":283},"obj":"http://purl.obolibrary.org/obo/GO_0006954"},{"id":"T2","span":{"begin":288,"end":299},"obj":"http://purl.obolibrary.org/obo/GO_0050817"}],"text":"The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation."}

{"project":"LitCovid-PubTator","denotations":[{"id":"72","span":{"begin":58,"end":68},"obj":"Chemical"},{"id":"73","span":{"begin":142,"end":150},"obj":"Species"},{"id":"74","span":{"begin":183,"end":191},"obj":"Disease"},{"id":"75","span":{"begin":201,"end":214},"obj":"Disease"},{"id":"76","span":{"begin":271,"end":283},"obj":"Disease"}],"attributes":[{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:D017984"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"Tax:9606"},{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"MESH:C000657245"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:D001102"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation."}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":311},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation."}

{"project":"Inflammaging","denotations":[{"id":"T3","span":{"begin":0,"end":311},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":311},"obj":"Sentence"}],"text":"The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation."}